249 related articles for article (PubMed ID: 21161341)
21. The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions.
Pavlakis K; Messini I; Vrekoussis T; Yiannou P; Keramopoullos D; Louvrou N; Liakakos T; Stathopoulos EN
BMC Cancer; 2008 Apr; 8():88. PubMed ID: 18384688
[TBL] [Abstract][Full Text] [Related]
22. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
O'Connell P; Pekkel V; Fuqua SA; Osborne CK; Clark GM; Allred DC
J Natl Cancer Inst; 1998 May; 90(9):697-703. PubMed ID: 9586667
[TBL] [Abstract][Full Text] [Related]
23. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
Liu TT; Li XF; Wang L; Yang JL
Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
[TBL] [Abstract][Full Text] [Related]
24. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
25. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
26. Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression.
Nelson AC; Machado HL; Schwertfeger KL
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):207-221. PubMed ID: 30168075
[TBL] [Abstract][Full Text] [Related]
27. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
28. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
Abdel-Fatah TM; Powe DG; Hodi Z; Reis-Filho JS; Lee AH; Ellis IO
Am J Surg Pathol; 2008 Apr; 32(4):513-23. PubMed ID: 18223478
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
Volinia S; Galasso M; Sana ME; Wise TF; Palatini J; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3024-9. PubMed ID: 22315424
[TBL] [Abstract][Full Text] [Related]
30. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.
Mao XY; Fan CF; Wei J; Liu C; Zheng HC; Yao F; Jin F
Tumour Biol; 2011 Dec; 32(6):1271-6. PubMed ID: 21909787
[TBL] [Abstract][Full Text] [Related]
31. The basic pathology of human breast cancer.
Mallon E; Osin P; Nasiri N; Blain I; Howard B; Gusterson B
J Mammary Gland Biol Neoplasia; 2000 Apr; 5(2):139-63. PubMed ID: 11149570
[TBL] [Abstract][Full Text] [Related]
32. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
33. [Lobular neoplasms and invasive lobular breast cancer].
Sinn HP; Helmchen B; Heil J; Aulmann S
Pathologe; 2014 Feb; 35(1):45-53. PubMed ID: 24435155
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.
McCart Reed AE; Song S; Kutasovic JR; Reid LE; Valle JM; Vargas AC; Smart CE; Simpson PT
Virchows Arch; 2013 Oct; 463(4):535-45. PubMed ID: 23942617
[TBL] [Abstract][Full Text] [Related]
35. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
36. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
37. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.
Schnitt SJ
Breast Cancer Res; 2009; 11(1):101. PubMed ID: 19291276
[TBL] [Abstract][Full Text] [Related]
38. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.
Simpson PT; Gale T; Reis-Filho JS; Jones C; Parry S; Sloane JP; Hanby A; Pinder SE; Lee AH; Humphreys S; Ellis IO; Lakhani SR
Am J Surg Pathol; 2005 Jun; 29(6):734-46. PubMed ID: 15897740
[TBL] [Abstract][Full Text] [Related]
39. Ras p21 in breast tissue: associations with pathology and cellular localisation.
Going JJ; Anderson TJ; Wyllie AH
Br J Cancer; 1992 Jan; 65(1):45-50. PubMed ID: 1733441
[TBL] [Abstract][Full Text] [Related]
40. Lobular neoplasia: frequency and association with other breast lesions.
Gomes DS; Balabram D; Porto SS; Gobbi H
Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
